545 related articles for article (PubMed ID: 8436564)
1. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
[TBL] [Abstract][Full Text] [Related]
2. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
6. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
Piddock LJ; Traynor EA; Griggs DJ
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci.
Fung-Tomc JC; Clark J; Minassian B; Pucci M; Tsai YH; Gradelski E; Lamb L; Medina I; Huczko E; Kolek B; Chaniewski S; Ferraro C; Washo T; Bonner DP
Antimicrob Agents Chemother; 2002 Apr; 46(4):971-6. PubMed ID: 11897577
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S
Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
[TBL] [Abstract][Full Text] [Related]
9. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
Entenza JM; Hohl P; Heinze-Krauss I; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2002 Jan; 46(1):171-7. PubMed ID: 11751129
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.
Fu KP; Foleno BD; Lafredo SC; LoCoco JM; Isaacson DM
Antimicrob Agents Chemother; 1993 Feb; 37(2):301-7. PubMed ID: 8452361
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y; Nouda H; Kanazawa K; Fukasawa M
Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
Climo MW; Markowitz SM; Williams DS; Hale-Cooper CG; Archer GL
J Antimicrob Chemother; 1997 Jul; 40(1):59-66. PubMed ID: 9249205
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
[TBL] [Abstract][Full Text] [Related]
14. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
16. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
Chambers HF
Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
Franciolli M; Bille J; Glauser MP; Moreillon P
J Infect Dis; 1991 Mar; 163(3):514-23. PubMed ID: 1995724
[TBL] [Abstract][Full Text] [Related]
19. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
Piddock LJ; Traynor EA; Wise R
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
